AR008820A1 - Comprimido dotado de recubrimiento laminar de maleato de trimebutina, destinado ala administracion por via oral, y un procedimiento para prepararlo - Google Patents

Comprimido dotado de recubrimiento laminar de maleato de trimebutina, destinado ala administracion por via oral, y un procedimiento para prepararlo

Info

Publication number
AR008820A1
AR008820A1 ARP970103538A ARP970103538A AR008820A1 AR 008820 A1 AR008820 A1 AR 008820A1 AR P970103538 A ARP970103538 A AR P970103538A AR P970103538 A ARP970103538 A AR P970103538A AR 008820 A1 AR008820 A1 AR 008820A1
Authority
AR
Argentina
Prior art keywords
preparing
intended
trimebutine maleate
administration
procedure
Prior art date
Application number
ARP970103538A
Other languages
English (en)
Original Assignee
Jouwsma Adriaan Jan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9494890&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR008820(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jouwsma Adriaan Jan filed Critical Jouwsma Adriaan Jan
Publication of AR008820A1 publication Critical patent/AR008820A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Abstract

Comprimido dotado de recubrimiento laminar de maleato de trimebutina destinado a la administracion por vía oral, caracterizado por comprender: -unnucleo que comprende de 30 a 60% de maleato de trimebutina, y excipientes adaptados a lapreparacion de dicho nucleo siendo éstos apropiados a la estabilidad y a la liberacion del principio activo, - un recubrimiento laminar hidrosoluble, de eficacia transitoria pero suficiente para preservar ladesintegracion al nucleo y de laliberacion p rematura del principio activo en el medio bucal. Un procedimiento para la fabricacion de comprimidos queconsiste en un primer momento en preparar un compuesto apropiado y después someterlo a compresion para obtener los nucleos que sondotados a continuacion de envolvente laminar.
ARP970103538A 1996-08-07 1997-08-04 Comprimido dotado de recubrimiento laminar de maleato de trimebutina, destinado ala administracion por via oral, y un procedimiento para prepararlo AR008820A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9609956A FR2752162B1 (fr) 1996-08-07 1996-08-07 Comprime de maleate de trimebutine pellicule

Publications (1)

Publication Number Publication Date
AR008820A1 true AR008820A1 (es) 2000-02-23

Family

ID=9494890

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP970103538A AR008820A1 (es) 1996-08-07 1997-08-04 Comprimido dotado de recubrimiento laminar de maleato de trimebutina, destinado ala administracion por via oral, y un procedimiento para prepararlo

Country Status (27)

Country Link
EP (1) EP0942718B1 (es)
JP (1) JP2000515535A (es)
KR (1) KR100539642B1 (es)
CN (1) CN1206986C (es)
AR (1) AR008820A1 (es)
AT (1) ATE300297T1 (es)
AU (1) AU3697097A (es)
BR (1) BR9711032B1 (es)
CA (1) CA2256751C (es)
CO (1) CO4900042A1 (es)
CZ (1) CZ294195B6 (es)
DZ (1) DZ2272A1 (es)
EA (1) EA001506B1 (es)
ES (2) ES2244002T3 (es)
FR (1) FR2752162B1 (es)
GR (1) GR1002907B (es)
HK (1) HK1020888A1 (es)
HU (1) HU228040B1 (es)
IT (1) IT1294671B1 (es)
MX (2) MXPA98010007A (es)
OA (1) OA10968A (es)
PL (1) PL188839B1 (es)
PT (2) PT942718E (es)
TN (1) TNSN97134A1 (es)
TR (1) TR199900261T2 (es)
UA (1) UA52682C2 (es)
WO (1) WO1998005320A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20001302A1 (es) 1998-11-27 2000-11-30 Hoffmann La Roche Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida
FR2834889B1 (fr) 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible
US20030181488A1 (en) 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
US7125563B2 (en) * 2002-04-12 2006-10-24 Dava Pharmaceuticals, Inc. Sustained release pharmaceutical preparations and methods for producing the same
EP1726621A1 (en) * 2005-05-26 2006-11-29 Cytec Surface Specialties, S.A. Thermosetting powder compositions
CN100393311C (zh) * 2006-01-26 2008-06-11 孙伟丰 马来酸曲美布汀分散片
CN1927185B (zh) * 2006-10-19 2010-05-19 开开援生制药股份有限公司 具速释部分的马来酸曲美布汀缓释片及其制备工艺
BRPI0916689A2 (pt) 2008-07-28 2015-11-17 Takeda Pharmaceutical composição farmacêutica estabilizada, preparação sólida, e, métodos para estabilizar uma composição farmacêutica, e para estabilizar uma preparação sólida.
KR101048487B1 (ko) * 2008-08-19 2011-07-11 한국콜마 주식회사 말레인산트리메부틴 서방정
KR101220829B1 (ko) * 2010-07-16 2013-01-10 안국약품 주식회사 트리메부틴 함유 서방성 정제
CN102462657A (zh) * 2010-11-15 2012-05-23 杭州赛利药物研究所有限公司 马来酸曲美布汀栓剂及其制备方法
WO2014148520A1 (ja) * 2013-03-21 2014-09-25 大正製薬株式会社 固形製剤
RU2536254C1 (ru) * 2013-11-26 2014-12-20 Общество С Ограниченной Ответственностью "Валента-Интеллект" Таблетки-ретард с тримебутином
CN107205984B (zh) * 2015-01-26 2019-11-12 第一三共株式会社 吡咯甲酰胺的固体组合物
RU2706166C2 (ru) * 2017-11-20 2019-11-14 Общество С Ограниченной Ответственностью "Валента - Интеллект" Новые полиморфные формы тримебутина малеата, способ получения и применения
RU2770300C2 (ru) * 2019-10-17 2022-04-15 Общество С Ограниченной Ответственностью "Валента - Интеллект" Новые полиморфные формы тримебутина малеата, способ получения и применения
RU2770301C2 (ru) * 2019-10-17 2022-04-15 Общество С Ограниченной Ответственностью "Валента - Интеллект" Новые полиморфные формы тримебутина малеата, способ получения и применения
CN113171353B (zh) * 2021-04-25 2022-10-21 海南普利制药股份有限公司 一种马来酸曲美布汀片

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045845B2 (ja) * 1979-10-31 1985-10-12 田辺製薬株式会社 医薬物質含有マイクロカプセルの製法
JPS57197214A (en) * 1981-05-29 1982-12-03 Tanabe Seiyaku Co Ltd Rapid-releasing microcapsule and its preparation
JPS5858146A (ja) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
JPS5858145A (ja) * 1981-10-05 1983-04-06 Tanabe Seiyaku Co Ltd 速放性マイクロカプセル
JPS5916821A (ja) * 1982-07-16 1984-01-28 Tanabe Seiyaku Co Ltd 非凝集性マイクロカプセルの製法
FR2640876B1 (es) * 1988-12-28 1993-09-24 Jouveinal Sa
JPH03275622A (ja) * 1990-03-26 1991-12-06 Teisan Seiyaku Kk マレイン酸トリメブチンを含有する経口固形製剤
JP2836493B2 (ja) * 1994-08-04 1998-12-14 田辺製薬株式会社 苦味隠蔽されたマレイン酸トリメブチン含有製剤

Also Published As

Publication number Publication date
EP0942718A1 (fr) 1999-09-22
PL188839B1 (pl) 2005-05-31
MX9706053A (es) 1998-02-28
ES2244002T3 (es) 2005-12-01
EA199900102A1 (ru) 1999-06-24
PT102031A (pt) 1998-02-27
MXPA98010007A (es) 2002-07-22
CZ37699A3 (cs) 1999-05-12
TNSN97134A1 (fr) 2005-03-15
CN1226162A (zh) 1999-08-18
IT1294671B1 (it) 1999-04-12
ES2130081B1 (es) 2000-01-01
CA2256751A1 (fr) 1998-02-12
HU228040B1 (en) 2012-09-28
BR9711032B1 (pt) 2008-11-18
ATE300297T1 (de) 2005-08-15
PT102031B (pt) 2004-07-30
KR100539642B1 (ko) 2005-12-29
EA001506B1 (ru) 2001-04-23
OA10968A (fr) 2001-10-30
PL331517A1 (en) 1999-07-19
BR9711032A (pt) 1999-08-17
CO4900042A1 (es) 2000-03-27
FR2752162B1 (fr) 1998-11-06
CZ294195B6 (cs) 2004-10-13
UA52682C2 (uk) 2003-01-15
CN1206986C (zh) 2005-06-22
HUP9902878A2 (hu) 2000-04-28
HUP9902878A3 (en) 2000-11-28
PT942718E (pt) 2005-10-31
JP2000515535A (ja) 2000-11-21
HK1020888A1 (en) 2000-05-26
WO1998005320A1 (fr) 1998-02-12
AU3697097A (en) 1998-02-25
CA2256751C (en) 2008-09-23
EP0942718B1 (fr) 2005-07-27
FR2752162A1 (fr) 1998-02-13
DZ2272A1 (fr) 2004-06-20
ES2130081A1 (es) 1999-06-16
ITGE970067A1 (it) 1999-02-06
KR20000029866A (ko) 2000-05-25
TR199900261T2 (xx) 1999-04-21
GR1002907B (el) 1998-05-13

Similar Documents

Publication Publication Date Title
AR008820A1 (es) Comprimido dotado de recubrimiento laminar de maleato de trimebutina, destinado ala administracion por via oral, y un procedimiento para prepararlo
ES2167061T3 (es) Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino.
HK1087336A1 (en) Pharmaceutical composition comprising lumiracoxib
CO5170471A1 (es) Tabletas de liberacion modificada que incluyen amoxilina y clavulanato de potasio
AR024384A1 (es) UNA FORMA DE DOSIFICACIoN FARMACÉUTICA DE DISOLUCIoN INSTANTÁNEA Y UN MÉTODO PARA PREPARARLA
AR012358A1 (es) Formulaciones de liberacion prolongada de derivados de eritromicina y su uso para la manufactura de un medicamento
AR040722A1 (es) Formulaciones y formas de dosificacion para la administracion controlada de topiramato
AR035642A1 (es) Uso de una composicion de celecoxib para el alivio rapido del dolor
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
EP0966966A3 (en) Nefazodone dosage form
BG105857A (en) Pregelatinized starch in a controlled release formulation
AU1227899A (en) Osmotic medicament releasing system
TR200102385T2 (tr) Kendiliğinden çözülür N-benzoil staurosporin kompozisyonları.
CO5160287A1 (es) Formulacion de liberacion controlada de divalproex sodico
AR018166A1 (es) Productos utilizables en el tratamiento de tumores, una composicion farmaceutica y el uso de una antraciclina sola o con un inhibidor de topoisomerasa iantineoplasico en la preparacion de medicamentos
BG108516A (en) Pharmaceutical formulation
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
AR034813A1 (es) Composiciones farmaceuticas y uso de las mismas
IL158668A0 (en) Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
WO2002011694A3 (en) COMPOSITIONS AND DOSAGE FORMS FOR APPLICATION IN ORAL CAVITY IN THE TREATMENT OF MYCOSIS
AP1485A (en) Orally administered controlled delivery system for once daily administration of ciprofloxacin.
HUP0203148A2 (hu) Mirtazapint tartalmazó orálisan dezintegrálódó készítmény
ZA951588B (en) Antitussive composition
IL157539A0 (en) A stable pharmaceutical formulation comprising torsemide modification ii
WO2010019279A8 (en) Pharmaceutical compositions configured to deter dosage form splitting

Legal Events

Date Code Title Description
FG Grant, registration